Risk of Adverse Neurocognitive Outcomes With PCSK-9 Inhibitors.
Sign Up to like & getrecommendations! Published in 2017 at "Journal of the American College of Cardiology"
DOI: 10.1016/j.jacc.2017.03.583
Abstract: The paper by Robinson et al. [(1)][1] suggested that low-density lipoprotein cholesterol (LDL-C) values read more here.
Keywords: cardiology; risk adverse; adverse neurocognitive; pcsk inhibitors ... See more keywords
Recent Advances on the Roles of PCSK-9 Inhibitors in the Management of Acute Ischemic Stroke Patients
Sign Up to like & getrecommendations! Published in 2022 at "International Journal of Molecular Sciences"
DOI: 10.3390/ijms231810221
Abstract: Acute ischemic stroke (AIS) represents an important cause of disability and death. Since only a minor percentage of patients with AIS are eligible for acute therapy, the management of risk factors is mandatory. An important… read more here.
Keywords: management; acute ischemic; ischemic stroke; pcsk inhibitors ... See more keywords